Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The Opportunity of Precision Medicine for Breast Cancer With Context-Sensitive Tumor Suppressor Maspin.

Bernardo MM, Dzinic SH, Matta MJ, Dean I, Saker L, Sheng S.

J Cell Biochem. 2017 Jul;118(7):1639-1647. doi: 10.1002/jcb.25969. Epub 2017 Mar 21. Review.

2.

The secretion and biological function of tumor suppressor maspin as an exosome cargo protein.

Dean I, Dzinic SH, Bernardo MM, Zou Y, Kimler V, Li X, Kaplun A, Granneman J, Mao G, Sheng S.

Oncotarget. 2017 Jan 31;8(5):8043-8056. doi: 10.18632/oncotarget.13302.

3.

An Essential Role of Maspin in Embryogenesis and Tumor Suppression.

Dzinic SH, Bernardo MM, Li X, Fernandez-Valdivia R, Ho YS, Mi QS, Bandyopadhyay S, Lonardo F, Vranic S, Oliveira DS, Bonfil RD, Dyson G, Chen K, Omerovic A, Sheng X, Han X, Wu D, Bi X, Cabaravdic D, Jakupovic U, Wahba M, Pang A, Harajli D, Sakr WA, Sheng S.

Cancer Res. 2017 Feb 15;77(4):886-896. doi: 10.1158/0008-5472.CAN-16-2219. Epub 2016 Dec 6.

4.

The mouse prostate: a basic anatomical and histological guideline.

Oliveira DS, Dzinic S, Bonfil AI, Saliganan AD, Sheng S, Bonfil RD.

Bosn J Basic Med Sci. 2016 Feb 10;16(1):8-13. doi: 10.17305/bjbms.2016.917. Review.

5.

Tumor suppressor maspin as a modulator of host immune response to cancer.

Dzinic SH, Bernardo MM, Oliveira DS, Wahba M, Sakr W, Sheng S.

Bosn J Basic Med Sci. 2015 Oct 25;15(4):1-6. doi: 10.17305/bjbms.2015.783. Review.

6.

A phase II trial of ganetespib, a heat shock protein 90 Hsp90) inhibitor, in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study.

Thakur MK, Heilbrun LK, Sheng S, Stein M, Liu G, Antonarakis ES, Vaishampayan U, Dzinic SH, Li X, Freeman S, Smith D, Heath EI.

Invest New Drugs. 2016 Feb;34(1):112-8. doi: 10.1007/s10637-015-0307-6. Epub 2015 Nov 18.

PMID:
26581400
7.

Maspin Expression in Prostate Tumor Cells Averts Stemness and Stratifies Drug Sensitivity.

Bernardo MM, Kaplun A, Dzinic SH, Li X, Irish J, Mujagic A, Jakupovic B, Back JB, Van Buren E, Han X, Dean I, Chen YQ, Heath E, Sakr W, Sheng S.

Cancer Res. 2015 Sep 15;75(18):3970-9. doi: 10.1158/0008-5472.CAN-15-0234. Epub 2015 Jul 24.

8.

Maspin expression in prostate tumor elicits host anti-tumor immunity.

Dzinic SH, Chen K, Thakur A, Kaplun A, Bonfil RD, Li X, Liu J, Bernardo MM, Saliganan A, Back JB, Yano H, Schalk DL, Tomaszewski EN, Beydoun AS, Dyson G, Mujagic A, Krass D, Dean I, Mi QS, Heath E, Sakr W, Lum LG, Sheng S.

Oncotarget. 2014 Nov 30;5(22):11225-36.

9.

Maspin expression patterns differ in the invasive versus lepidic growth pattern of pulmonary adenocarcinoma.

Lonardo F, Guan H, Dzinic S, Sheng S.

Histopathology. 2014 Dec;65(6):757-63. doi: 10.1111/his.12485. Epub 2014 Sep 9.

10.

Identification of an intrinsic determinant critical for maspin subcellular localization and function.

Dzinic SH, Kaplun A, Li X, Bernardo M, Meng Y, Dean I, Krass D, Stemmer P, Shin N, Lonardo F, Sheng S.

PLoS One. 2013 Nov 21;8(11):e74502. doi: 10.1371/journal.pone.0074502. eCollection 2013.

11.

Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).

Wang Y, Sheng S, Zhang J, Dzinic S, Li S, Fang F, Wu N, Zheng Q, Yang Y.

PLoS One. 2013 May 22;8(5):e63581. doi: 10.1371/journal.pone.0063581. Print 2013. Erratum in: PLoS One. 2014;9(8):e104715.

12.

Tumor suppressor maspin as a rheostat in HDAC regulation to achieve the fine-tuning of epithelial homeostasis.

Kaplun A, Dzinic S, Bernardo M, Sheng S.

Crit Rev Eukaryot Gene Expr. 2012;22(3):249-58. Review.

13.

Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.

Bernardo MM, Meng Y, Lockett J, Dyson G, Dombkowski A, Kaplun A, Li X, Yin S, Dzinic S, Olive M, Dean I, Krass D, Moin K, Bonfil RD, Cher M, Sakr W, Sheng S.

Genes Cancer. 2011 Nov;2(11):1009-22. doi: 10.1177/1947601912440170.

14.

Smoking and other personal characteristics as potential predictors for fecal bacteria populations in humans.

Kato I, Nechvatal JM, Dzinic S, Basson MD, Majumdar AP, Ram JL.

Med Sci Monit. 2010 Jan;16(1):CR1-7.

15.

Bacterial chemotaxis differences in Escherichia coli isolated from different hosts.

Dzinic SH, Luercio M, Ram JL.

Can J Microbiol. 2008 Dec;54(12):1043-52. doi: 10.1139/W08-105.

PMID:
19096459
16.

Variable length tandem repeat polyglutamine sequences in the flexible tether region of the Tsr chemotaxis receptor of Escherichia coli.

Dzinic SH, Shukla M, Mandija I, Ram TS, Ram JL.

Microbiology. 2008 Aug;154(Pt 8):2380-6. doi: 10.1099/mic.0.2008/016303-0.

PMID:
18667570
17.

[Effect of prostigmine on the choline content in frog].

KOSAK R, STERN P, DZINIC S.

Acta Med Iugosl. 1953;7(3):204-7. Undetermined Language. No abstract available.

PMID:
13123786
18.

[Effect of cardiac glycosides in alloxan diabetes in cats].

DZINIC S.

Acta Med Iugosl. 1952;6(2-3):217-22. Undetermined Language. No abstract available.

PMID:
12975984
19.

[Intracellular cholin esterase].

BEGOVIC S, DZINIC S, KOSAK R, STERN P.

Acta Neuroveg (Wien). 1951;3(3-4):551-8. Undetermined Language. No abstract available.

PMID:
14932909

Supplemental Content

Loading ...
Support Center